LORETA SHAHINAJ: Open Payments
NPI 1952816449 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,226 in 53 payments from 15 companies in 2025. Trend: 2023 $1,018 · 2024 $1,470 · 2025 $1,226
Food & beverage: $1,226
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $456 |
| Amgen Inc. | 6 | $126 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| GENZYME CORPORATION | 2 | $93 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| Janssen Biotech, Inc. | 4 | $83 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| PFIZER INC. | 2 | $39 |
| ANI Pharmaceuticals, Inc. | 2 | $37 |
| UCB, Inc. | 1 | $27 |
Products named: RINVOQ, SKYRIZI, KEVZARA, SAPHNELO, TREMFYA, BENLYSTA, COSENTYX, KRYSTEXXA.
Industry payments across MO — which companies pay providers there.
